| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8229296 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
Severe acute pulmonary toxicity is prevalent after TBI-based myeloablative conditioning regimens, occurring in approximately 33% of patients. The number of prior chemotherapy regimens appears to be an important risk factor.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chris R. M.D., Mitchell E. M.D., Junzo P. M.D., Oana Ph.D., Beverly M.S., Rodney J. M.D. Ph.D., Nelson J. M.D., David A. M.D., Lawrence B. M.D.,